CAMARGO

Pharmaceutical drug development services, namely, pre-clinical feasibility assessments, chemistry, manufacturing, and control services, contracting contract research organization services, Phase II and Phase III studies, clinical trials, regulatory review and submission via Electronic Common Technical Document of Investigational New Drug, New Drug Application, and Abbreviated New Drug Application, and drug applications that are covered by Section 505 (b) (2) of the Federal Food Drug, and Cosmetic Act